UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$21.6B |
| 2 |
Amazon
AMZN
|
+$13.7B |
| 3 |
NVIDIA
NVDA
|
+$3.87B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$1.89B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$22.7B |
| 2 |
Equinix
EQIX
|
+$857M |
| 3 |
Digital Realty Trust
DLR
|
+$655M |
| 4 |
NetEase
NTES
|
+$618M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$609M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.9% |
| 2 | Financials | 13.9% |
| 3 | Consumer Discretionary | 11.31% |
| 4 | Healthcare | 10.7% |
| 5 | Communication Services | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
101
Alcon
ALC
$30.8B
| $1.03B | 0.21% |
11,651,195
-75,112
| -0.6% | -$6.74M |
2024 Q2
4 quarters
|
|
102
GE Vernova
GEV
$266B
| $1.02B | 0.21% |
1,934,056
-145,950
| -7% | -$60.8M |
2024 Q2
4 quarters
|
|
103
RTX Corp
RTX
$250B
| $1.02B | 0.21% |
6,987,090
+607,630
| +10% | +$81M |
2013 Q2
48 quarters
|
|
104
Synopsys
SNPS
$97.3B
| $987M | 0.2% |
1,925,356
+109,037
| +6% | +$50.8M |
2013 Q2
48 quarters
|
|
105
Pinduoduo
PDD
$114B
| $967M | 0.2% |
9,239,441
+253,472
| +3% | +$26.6M |
2018 Q4
26 quarters
|
|
106
Cigna
CI
$74.4B
| $952M | 0.19% |
2,878,593
+411,687
| +17% | +$133M |
2013 Q2
48 quarters
|
|
107
McKesson
MCK
$109B
| $948M | 0.19% |
1,294,232
+9,351
| +0.7% | +$6.6M |
2013 Q2
48 quarters
|
|
|
FISV
108
Fiserv Inc
FISV
$24.3B
| $937M | 0.19% |
5,437,382
+821,113
| +18% | +$149M |
2013 Q2
48 quarters
|
|
109
Moody's
MCO
$80B
| $936M | 0.19% |
1,866,893
+215,398
| +13% | +$99.8M |
2013 Q2
48 quarters
|
|
110
Amphenol
APH
$214B
| $926M | 0.19% |
18,753,132
+1,235,230
| +7% | +$50.5M |
2013 Q2
48 quarters
|
|
111
Stryker
SYK
$107B
| $913M | 0.18% |
2,307,552
+220,592
| +11% | +$82.5M |
2013 Q2
48 quarters
|
|
112
Medtronic
MDT
$113B
| $901M | 0.18% |
10,332,662
+1,551,919
| +18% | +$132M |
2013 Q2
48 quarters
|
|
113
Chubb
CB
$132B
| $898M | 0.18% |
3,099,871
+315,818
| +11% | +$90.9M |
2013 Q2
48 quarters
|
|
114
Waste Management
WM
$83.2B
| $882M | 0.18% |
3,855,347
+512,080
| +15% | +$119M |
2013 Q2
48 quarters
|
|
115
CME Group
CME
$101B
| $868M | 0.18% |
3,148,705
+420,896
| +15% | +$114M |
2013 Q2
48 quarters
|
|
116
Apollo Global Management
APO
$69.8B
| $857M | 0.17% |
6,042,038
+1,132,010
| +23% | +$150M |
2019 Q4
22 quarters
|
|
117
Honeywell
HON
$65.8B
| $846M | 0.17% |
3,854,728
+384,005
| +11% | +$77.7M |
2013 Q2
48 quarters
|
|
118
Johnson Controls International
JCI
$95.2B
| $842M | 0.17% |
7,974,065
+1,619,996
| +25% | +$149M |
2013 Q2
48 quarters
|
|
119
iShares Core S&P 500 ETF
IVV
$897B
| $825M | 0.17% |
1,328,806
-91,801
| -6% | -$52.7M |
2024 Q2
4 quarters
|
|
120
Zoetis
ZTS
$30.7B
| $807M | 0.16% |
5,174,732
+922,035
| +22% | +$146M |
2013 Q2
48 quarters
|
|
121
DexCom
DXCM
$31.6B
| $797M | 0.16% |
9,130,614
-992,911
| -10% | -$77.8M |
2013 Q2
48 quarters
|
|
122
Travelers Companies
TRV
$76.8B
| $787M | 0.16% |
2,942,317
+2,341,706
| +390% | +$617M |
2013 Q2
48 quarters
|
|
123
Zscaler
ZS
$36.9B
| $760M | 0.15% |
2,420,254
-707,916
| -23% | -$176M |
2018 Q4
26 quarters
|
|
124
Fortinet
FTNT
$141B
| $756M | 0.15% |
7,148,244
+131,777
| +2% | +$13.3M |
2013 Q2
48 quarters
|
|
125
HCA Healthcare
HCA
$96.7B
| $754M | 0.15% |
1,967,375
+307,728
| +19% | +$111M |
2013 Q2
48 quarters
|
|
Similar funds
UBS AM's Q2 2025 Portfolio in Review
As of Q2 2025, UBS AM held 2,749 positions worth $494B, up 26% from $391B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
UBS AM deployed $54.3B of net new capital in Q2 2025, opening 106 new positions and adding to 2,036 existing holdings. Its largest new stake was Amrize Ltd: 12,343,881 shares worth $612M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Microsoft, an estimated $22.7B trimmed.
- UBS AM's largest Q2 2025 buy was Amrize Ltd: 12,343,881 shares worth $612M.
- UBS AM added most to Apple in Q2 2025, an estimated $21.6B increase.
- UBS AM's biggest Q2 2025 reduction was Microsoft, cutting an estimated $22.7B.
- UBS AM fully exited Discover Financial Services in Q2 2025, selling an estimated $356M.
- UBS AM's ten largest holdings make up 28% of its $494B portfolio in Q2 2025.
- UBS AM opened 106 new positions and closed 128 in Q2 2025.
- UBS AM's portfolio value rose 26% quarter-over-quarter to $494B.
Based on UBS AM's 13F filing for Q2 2025, filed 14 Aug 2025.